Health
EDAN Expands U.S. Operations with New Manufacturing Hub
Facility marks EDAN's 30th anniversary and kickstarts global supply chain
ecosystem
SAN DIEGO, Oct. 8, 2025 /PRNewswire/ -- Edan Instruments, Inc.
2025-10-09 06:53
984
TCI Biotech Releases 2024 ESG Report, Showcasing Brand Transformation, Global Sustainability Commitments, and Award-Winning Impact
SALT LAKE CITY, Oct. 8, 2025 /PRNewswire/ -- TCI Biotech, a global biotechnology leader in health and wellness, today announced the release of its 2024 Environmental, Social, and Governance (ESG) Report, marking a milestone year of brand renewal, international sustainability recognition, and meas...
2025-10-08 23:00
964
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025
BARCELONA, Spain, Oct. 8, 2025 /PRNewswire/ -- During the 2025 Annual Congress of the European Association of Nuclear Medicine (EANM 2025), C-Ray Therapeutics (Shanghai) Co., Ltd. ("C-Ray Shanghai"), a company dedicated to the development of innovative targeted radiopharmaceuticals, announced pro...
2025-10-08 22:20
1032
Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System
〜Driving Technology Transfer and Test Manufacturing Following Regulatory Approval to Launch Company-Led af-001 Trial〜 TOKYO, Oct. 8, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Alpha Fusion) is proud to announce a joint initiative with the Kobe City Medical Center General Hospital (KCGH) to establis...
2025-10-08 21:00
1088
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering
GUANGZHOU, China, Oct. 8, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases inChina, today announced the pricing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at...
2025-10-08 20:00
1436
Covation Biomaterials Highlights Milestones for CovationBio® bioPTMEG at K-Show 2025
DUSSELDORF, Germany, Oct. 8, 2025 /PRNewswire/ -- Covation Biomaterials LLC ("CovationBio® "), a biomaterials company with advanced technology in the bio-based materials industry, is excited to share project milestones and updates for their newest innovation, CovationBio® bioPTMEG at K 2025, the ...
2025-10-08 16:06
1339
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment
HMI-115 demonstrated statistically significant improvement in endometriosis pain The mean dysmenorrhea pain score was reduced by 42% The mean non-menstrual pelvic pain score was reduced by 52% Most of the patients had normal menstrual periods No typical peri-menopausal symptoms were reported Th...
2025-10-08 09:08
1697
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology
SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of CT071 (an autologous CAR T-cell product targeting GPRC5D) for the treatment of relapsed/refractory mul...
2025-10-08 08:15
1256
Celaid Therapeutics Raises JPY 1.055 Billion (USD 7.2 Million) in the First Close of its Series B Financing
TOKYO, Oct. 7, 2025 /PRNewswire/ -- Celaid Therapeutics Inc. ("Celaid"), today announced the successful completion of the 1st Close of its Series B financing round, raisingJPY 1.055 billion (USD 7.2 million) from venture capital firms and the Japan Agency for Medical Research and Development (AME...
2025-10-07 21:00
1405
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized...
2025-10-07 20:30
1818
Yesoul T3S Plus Auto-Incline Treadmill with Free Screen Mirroring: Affordable Innovation for Your Marathon Training at Home
HONG KONG, Oct. 6, 2025 /PRNewswire/ -- For many people, finding time to exercise feels impossible. After a long day at work, commuting home, preparing meals, and taking care of family, the idea of heading to a crowded gym is exhausting. Even when you carve out time at home, traditional treadmill...
2025-10-06 19:00
1467
FDA Lifts Clinical Hold on NUZ-001
Highlights: * U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS * Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 * IND supported by robust preclinical safety data and comprehensive manufacturing and ...
2025-10-06 14:06
1352
Why Travel for Wellness: ASICS Reveals 15 Minutes of Movement Can Boost Your Mood More Than a Week at a Wellness Retreat
This World Mental Health Day, ASICS invites everyone to take an Everyday Escape, showing you don't need to travel far or spend big to take your body and mind to a happier place. * ASICS enlists Natasha Rothwell to champion movement as a more accessible and effective alternative to wellness hol...
2025-10-06 07:01
1326
Mediso installs true theranostic TheraMAX SPECT/CT at Heidelberg University Hospital
HEIDELBERG, Germany, Oct. 3, 2025 /PRNewswire/ -- Mediso completes the
installation of an AnyScan® TRIO-TheraMAX SPECT/CT at the Department of Nuclear
Medicine at Heidelberg University Hospital.
2025-10-03 15:39
1357
MedHub-AI Announces National Reimbursement Approval in Japan for AutocathFFR™
TEL AVIV, Israel, Oct. 3, 2025 /PRNewswire/ -- MedHub-AI
2025-10-03 07:00
1395
Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States
* The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as the reference product ACTEMRA® (tocilizumab) * AVTOZMA is Celltrion's fifth immunology biologic and seventh biosimilar approved by the FDA * This launch stre...
2025-10-02 20:30
1644
AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing
* Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional medicine with state-of-the-art technologies. * Patented Flagship NB-A002 is a First-in-class DNA...
2025-10-02 19:50
4345
Vatech Launches 'Boundless Campaign' to Eliminate Barriers in Dental Care
First milestone: reduced device operation time update eases discomfort for elderly and disabled patients SEOUL, South Korea, Oct. 1, 2025 /PRNewswire/ -- Vatech (KOSDAQ: 043150), a global leader in dental imaging solutions, today announced the launch of its 'Boundless Campaign' a long-term initia...
2025-10-01 21:00
1288
MD Logistics Makes Largest Indiana Business Location Fully cGMP-compliant
- Total Area of 37,000m2, Enhanced Pharmaceutical Logistics Capacity - TOKYO, Oct. 1, 2025 /PRNewswire/ -- MD Logistics LLC (hereinafter "MD Logistics"), a group company of NIPPON EXPRESS HOLDINGS, INC., completed renovation of the South Area of its largest logistics base inPlainfield, in the U....
2025-10-01 15:00
1282
TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World's First Apixaban Oral Dissolving Film - Represents a Transformational Advancement in Anticoagulant Therapy
TAIPEI, Oct. 1, 2025 /PRNewswire/ -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world's first Apixaban Oral Dissolving Film (ODF). This submission marks a significant re...
2025-10-01 14:16
1366
Week's Top Stories
Most Reposted
Senetas and Nokia Announce Strategic Alliance to Secure Mission-Critical Networks for Defence and Government
[Picked up by 312 media titles]
2025-11-27 07:25SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 292 media titles]
2025-11-29 09:00
Pop the 90s: The Westin Surabaya and Four Points Pakuwon Indah Welcomes 2026 with a Spectacular Live Show Featuring Project Pop
[Picked up by 286 media titles]
2025-11-26 10:49
Lincah Acquires Orderfaz to Strengthen Southeast Asia's Social Commerce Infrastructure
[Picked up by 283 media titles]
2025-11-26 09:00
Singapore Hosts Record-Breaking World Robot Olympiad (WRO®) International Final 2025
[Picked up by 282 media titles]
2025-11-27 08:00
Most Read
MINISO Unveils Australia's First and Largest MINISO LAND Flagship at Sydney Chatswood
2025-11-27 18:56
2500
